Literature DB >> 21705621

A TCR transgenic mouse reactive with multiple systemic dimorphic fungi.

Marcel Wüthrich1, Chiung Yu Hung, Ben H Gern, John C Pick-Jacobs, Kevin J Galles, Hanna I Filutowicz, Garry T Cole, Bruce S Klein.   

Abstract

Dimorphic fungi collectively account for 5-10 million new infections annually worldwide. Ongoing efforts seek to clarify mechanisms of cellular resistance to these agents and develop vaccines. A major limitation in studying the development of protective T cells in this group of organisms is the lack of tools to detect, enumerate, and characterize fungus-specific T cells during vaccination and infection. We generated a TCR transgenic mouse (Bd 1807) whose CD4(+) T cells respond to a native epitope in Blastomyces dermatitidis and also in Histoplasma capsulatum. In this study, we characterize the mouse, reveal its applications, and extend our analysis showing that 1807 cells also respond to the related dimorphic fungi Coccidioides posadasii and Paracoccidioides lutzii. On adoptive transfer into vaccinated wild-type mice, 1807 cells become activated, proliferate, and expand in the draining lymph nodes, and they differentiate into T1 effectors after trafficking to the lung upon lethal experimental challenge. Bd 1807 cells confer vaccine-induced resistance against B. dermatitidis, H. capsulatum, and C. posadasii. Transfer of naive 1807 cells at serial intervals postvaccination uncovered the prolonged duration of fungal Ag presentation. Using 1807 cells, we also found that the administration of vaccine only once induced a maximal pool of effector/memory CD4(+) cells and protective immunity by 4 wk after vaccination. The autologous adoptive transfer system described in this study reveals novel features of antifungal immunity and offers a powerful approach to study the differentiation of Ag-specific T cells responsive to multiple dimorphic fungi and the development of CD4(+) T cell memory needed to protect against fungal infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705621      PMCID: PMC3140549          DOI: 10.4049/jimmunol.1100921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.

Authors:  Vladimir P Badovinac; Jodie S Haring; John T Harty
Journal:  Immunity       Date:  2007-06-07       Impact factor: 31.745

2.  Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells.

Authors:  David A Blair; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-07       Impact factor: 11.205

3.  Naive and memory CD4+ T cell survival controlled by clonal abundance.

Authors:  Jason Hataye; James J Moon; Alexander Khoruts; Cavan Reilly; Marc K Jenkins
Journal:  Science       Date:  2006-03-02       Impact factor: 47.728

4.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.

Authors:  James J Moon; H Hamlet Chu; Marion Pepper; Stephen J McSorley; Stephen C Jameson; Ross M Kedl; Marc K Jenkins
Journal:  Immunity       Date:  2007-08-16       Impact factor: 31.745

5.  The alphabeta T cell repertoire comes into focus.

Authors:  Mark M Davis
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

6.  Innate immune activation and CD4+ T cell priming during respiratory fungal infection.

Authors:  Amariliz Rivera; Grace Ro; Heather L Van Epps; Tyler Simpson; Ingrid Leiner; Derek B Sant'Angelo; Eric G Pamer
Journal:  Immunity       Date:  2006-10-05       Impact factor: 31.745

7.  V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis.

Authors:  Marcel Wüthrich; Hanna I Filutowicz; Holly L Allen; George S Deepe; Bruce S Klein
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

8.  CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.

Authors:  Deborah M Brown; Allison M Dilzer; Dana L Meents; Susan L Swain
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

9.  Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation.

Authors:  Dawn M Jelley-Gibbs; Deborah M Brown; John P Dibble; Laura Haynes; Sheri M Eaton; Susan L Swain
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

10.  Repeated stimulation of CD4 effector T cells can limit their protective function.

Authors:  Dawn M Jelley-Gibbs; John P Dibble; Svetlana Filipson; Laura Haynes; Roslyn A Kemp; Susan L Swain
Journal:  J Exp Med       Date:  2005-03-28       Impact factor: 14.307

View more
  27 in total

1.  Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection.

Authors:  Marcel Wüthrich; Vanessa LeBert; Kevin Galles; Jane Hu-Li; Shlomo Z Ben-Sasson; William E Paul; Bruce S Klein
Journal:  J Infect Dis       Date:  2013-06-20       Impact factor: 5.226

Review 2.  Universal fungal vaccines: could there be light at the end of the tunnel?

Authors:  Mawieh Hamad
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

Review 3.  Immunity to fungi.

Authors:  Salomé LeibundGut-Landmann; Marcel Wüthrich; Tobias M Hohl
Journal:  Curr Opin Immunol       Date:  2012-05-19       Impact factor: 7.486

Review 4.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

5.  Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4+ T cells: robust activation and proliferation with weak effector function during recall.

Authors:  Marcel Wüthrich; Karen Ersland; John C Pick-Jacobs; Benjamin H Gern; Christopher A Frye; Thomas D Sullivan; Meghan B Brennan; Hanna I Filutowicz; Kevin O'Brien; Keegan D Korthauer; Stacey Schultz-Cherry; Bruce S Klein
Journal:  Infect Immun       Date:  2011-11-28       Impact factor: 3.441

Review 6.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

Review 7.  Adaptive immunity to fungi.

Authors:  Marcel Wüthrich; George S Deepe; Bruce Klein
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

8.  CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.

Authors:  Antonella De Luca; Rossana G Iannitti; Silvia Bozza; Remi Beau; Andrea Casagrande; Carmen D'Angelo; Silvia Moretti; Cristina Cunha; Gloria Giovannini; Cristina Massi-Benedetti; Agostinho Carvalho; Louis Boon; Jean-Paul Latgé; Luigina Romani
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

9.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

10.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.